Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients

Neurology

Volumn 60, Issue 11, 2003, Pages 1793-1798

  Christodoulou, Christopher ^a   Krupp, L B ^a   Liang, Z ^a,b   Huang, W ^a   Melville, P ^a   Roque, C ^a   Scherl, W F ^a   Morgan, T ^a   MacAllister, W S ^a   Li, L ^a   Tudorica, L A ^a   Li, X ^a   Roche, P ^a   Peyster, R ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Stony Brook University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CHOLINESTERASE INHIBITOR; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEMISPHERE; HUMAN; IMAGING; LEARNING; MALE; MEMORY; MENTAL FUNCTION; MULTIPLE REGRESSION; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; TASK PERFORMANCE;

EID: 10744231464     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000072264.75989.B8     Document Type: Article

References (40)

1. Rao SM, Leo GJ, Bernardin L, Unvergagt F. Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns and prediction. Neurology 1991;41:685-691.
2. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: II. Impact on employment and social functioning. Neurology 1991;41:692-696.
3. Schultheis MT, Garay E, DeLuca J. The influence of cognitive impairment on driving performance in multiple sclerosis. Neurology 2001;56:1089-1094.
4. Jagust WJ. Brain atrophy as a surrogate marker in MS: faster, simpler, better? Neurology 2000;54:782-783.
5. Fox NC, Jenkins R, Leary SM, et al. Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 2000;54:807-812.
6. Rao SM, Glatt S, Hammeke TA, et al. Chronic progressive multiple sclerosis: relationship between cerebral ventricular size and neuropsychological impairment. Arch Neurol 1985;42:678-682.
7. Pugnetti L, Mendozzi L, Motta A, et al. MRI and cognitive patterns in relapsing-remitting multiple sclerosis. J Neurol Sci 1993;155(suppl):S59-S65.
8. Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L, the Multiple Sclerosis Collaborative Research Group. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 1999;53:1698-1704.
9. Edwards SG, Liu C, Blumhardt LD. Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis. Acta Neurol Scand 2001;104:214-223.
10. Hohol MJ, Guttmann CR, Orav J, et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 1997;54:1018-1025.
11. Berg D, Maurer M, Warmuth-Metz M, Rieckmann P, Becker G. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch Neurol 2000;57:1289-1292.
12. Benedict RHB, Bakshi R, Simon JH, Priore R, Miller C, Munschauer F. Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2002;14:44-51.
13. Sperling RA, Guttman CRG, Hohol MJ, et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis. Arch Neurol 2001;58:115-121.
14. Sarchielli P, Presciutti O, Pelliccioli GP, et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal appearing white matter in multiple sclerosis patients. Brain 1999;122:513-521.
15. Bjartmar C, Kidd G, Ransohoff RM. A real-time insight into disease progression and the role of axonal injury in multiple sclerosis. Arch Neurol 2001;58:37-39.
16. De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001;58:65-70.
17. Foong J, Rozewics L, Davie CA, Thompson AJ, Miller DH, Ron MA. Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology. J Neuropsychiatry Clin Neurosci 1999;11:45-50.
18. Pan JW, Krupp LB, Elkins LE, Coyle PK. Cognitive dysfunction lateralizes with NAA in multiple sclerosis. Appl Neuropsychol 2001;8:155-160.
19. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
20. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd ed. New York: Oxford University Press, 1998.
21. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychol Res 1975;12:189-198.
22. Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
24. Rao SM, in collaboration with the Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis. Milwaukee: Medical College of Wisconsin, 1990.
25. Zakzanis KK. Distinct neuropsychological profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol 2000;15:115-136.
26. Camp SJ, Stevenson VL, Thompson AJ, et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999;122:1341-1348.
27. Weinstein A, Schwid SIL, Schiffer RB, McDermott MP, Giang DW, Goodman AD. Neuropsychological status in multiple sclerosis after treatment with glatiramer. Arch Neurol 1999;56:319-324.
28. Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000;55:934-939.
29. Foong J, Rozewicz L, Quaghebeur G, et al. Executive functioning in multiple sclerosis: the role of frontal lobe pathology. Brain 1997;120:15-26.
30. Glosser G, Goodglass H. Disorders in executive control functions among aphasic and other brain-damaged patients. J Clin Exp Neuropsychol 1990;12:485-501.
31. Li L, Li X, Huang W, et al. A novel mixture-based segmentation algorithm for quantitative analysis of multiple sclerosis using multi-spectral MR images. Proc Soc Magn Res Med 2002;10:354.
32. Simon JH. Brain and spinal cord atrophy in multiple sclerosis. Neuroimag Clin North Am 2000;10:753-769.
33. Tabachnick BG, Fidell LS. Using multivariate statistics. 3rd ed. New York: Harper Collins, 1996.
34. Boringa JB, Lazeron RHC, Reuling IEW, et al. The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001;7:263-267.
35. Bever CT, Grattan L, Panitch HS, Johnson KP. The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study. Mult Scler 1995;1:165-169.
36. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum, 1988.
37. Snyder PJ, Cappalleri JC, Archibald CJ, Fisk JD. Improved detection of differential information-processing speed deficits between two disease-course types of multiple sclerosis. Neuropsychology 2001;15:617-625.
38. Mainero C, De Stefano N, Iannucci G. Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology 2001;56:1331-1334.
39. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15:239-245.
40. Kalkers NF, Bergers L, de Groot V. Concurrent validity of the MS functional composite using MRI as a biological disease marker. Neurology 2001;56:215-219.